Barac A, Murtagh G, Carver JR, Chen MH, Freeman AM, Herrmann J, Iliescu C, Ky B, Mayer EL, Okwuosa TM, Plana JC, Ryan TD, Rzeszut AK, Douglas PS (2015) Cardiovascular health of patients with cancer and cancer survivors: a roadmap to the next level. J Am Coll Cardiol 65(25):2739–2746
Article PubMed PubMed Central Google Scholar
Hayek SS, Ganatra S, Lenneman C, Scherrer-Crosbie M, Leja M, Lenihan DJ, Yang E, Ryan TD, Liu J, Carver J, Mousavi N, O’Quinn R, Arnold A, Banchs J, Barac A, Ky B (2019) Preparing the cardiovascular workforce to care for oncology patients: JACC review topic of the week. J Am Coll Cardiol 73(17):2226–2235
Article PubMed PubMed Central Google Scholar
Armstrong GT, Oeffinger KC, Chen Y, Kawashima T, Yasui Y, Leisenring W, Stovall M, Chow EJ, Sklar CA, Mulrooney DA, Mertens AC, Border W, Durand JB, Robison LL, Meacham LR (2013) Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol 31(29):3673–3680
Article PubMed PubMed Central Google Scholar
Curigliano G, Cardinale D, Dent S, Criscitiello C, Aseyev O, Lenihan D, Cipolla CM (2016) Cardiotoxicity of anticancer treatments: epidemiology, detection, and management. CA Cancer J Clin 66(4):309–325
Florido R, Daya NR, Ndumele CE, Koton S, Russell SD, Prizment A, Blumenthal RS, Matsushita K, Mok Y, Felix AS, Coresh J, Joshu CE, Platz EA, Selvin E (2022) Cardiovascular disease risk among cancer survivors: the Atherosclerosis Risk In Communities (ARIC) study. J Am Coll Cardiol 80(1):22–32
Article PubMed PubMed Central Google Scholar
Navi BB, Reiner AS, Kamel H, Iadecola C, Okin PM, Elkind MSV, Panageas KS, DeAngelis LM (2017) Risk of arterial thromboembolism in patients with cancer. J Am Coll Cardiol 70(8):926–938
Article PubMed PubMed Central Google Scholar
Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ, Lip GYH, Lyon AR, Lopez Fernandez T, Mohty D, Piepoli MF, Tamargo J, Torbicki A, Suter TM (2016) 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J 37(36):2768–2801
Bharadwaj A, Potts J, Mohamed MO, Parwani P, Swamy P, Lopez-Mattei JC, Rashid M, Kwok CS, Fischman DL, Vassiliou VS, Freeman P, Michos ED, Mamas MA (2020) Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA. Eur Heart J 41(23):2183–2193
Article CAS PubMed Google Scholar
Kaneko H, Itoh H, Yotsumoto H, Kiriyama H, Kamon T, Fujiu K, Morita K, Michihata N, Jo T, Takeda N (2020) Association of cancer with outcomes in patients hospitalized for heart failure. Circ J 84(10):1771–1778
Miyanaga S, Komukai K, Kubota T, Shirasaki K, Oki Y, Yoshida R, Fukushima K, Maehara T, Yamamoto H, Niijima A (2022) Cancer and malnutrition were independently associated with a poor prognosis in patients with heart failure. J Cardiol 79(1):15–20
Aapro M, Arends J, Bozzetti F, Fearon K, Grunberg SM, Herrstedt J, Hopkinson J, Jacquelin-Ravel N, Jatoi A, Kaasa S, Strasser F (2014) Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology task force. Ann Oncol 25(8):1492–1499
Article CAS PubMed Google Scholar
Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12(5):489–495
Peixoto da Silva S, Santos JMO, Costa ESMP, Gil da Costa RM, Medeiros R (2020) Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia. J Cachexia Sarcopenia Muscle 11(3):619–635
Article PubMed PubMed Central Google Scholar
André N, Gastinger S, Rébillard A (2021) Chronic fatigue in cancer, brain connectivity and reluctance to engage in physical activity: a mini-review. Front Oncol 11:774347
Article PubMed PubMed Central Google Scholar
Kerckhove N, Collin A, Condé S, Chaleteix C, Pezet D, Balayssac D, Guastella V (2018) Chemotherapy-induced peripheral neuropathy: symptomatology and epidemiology. Bull Cancer 105(11):1020–1032
O’Higgins CM, Brady B, O’Connor B, Walsh D, Reilly RB (2018) The pathophysiology of cancer-related fatigue: current controversies. Support Care Cancer 26(10):3353–3364
Article CAS PubMed Google Scholar
Pin F, Barreto R, Couch ME, Bonetto A, O’Connell TM (2019) Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism. J Cachexia Sarcopenia Muscle 10(1):140–154
Article PubMed PubMed Central Google Scholar
Stone JB, DeAngelis LM (2016) Cancer-treatment-induced neurotoxicity–focus on newer treatments. Nat Rev Clin Oncol 13(2):92–105
Article CAS PubMed Google Scholar
Wustrack R, Rao SS, Morris CD (2020) Musculoskeletal effects of cancer and cancer treatment. J Am Acad Orthop Surg 28(16):e716–e728
Kamiya K, Hamazaki N, Matsuzawa R, Nozaki K, Tanaka S, Ichinosawa Y, Maekawa E, Noda C, Yamaoka-Tojo M, Matsunaga A (2017) Sarcopenia: prevalence and prognostic implications in elderly patients with cardiovascular disease. JCSM Clin Rep 2(2):1–13
von Haehling S, Doehner W, Anker SD (2007) Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure. Cardiovasc Res 73(2):298–309
(2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111–117
Damluji AA, Alfaraidhy M, AlHajri N, Rohant NN, Kumar M, Al Malouf C, Bahrainy S, Ji Kwak M, Batchelor WB, Forman DE, Rich MW, Kirkpatrick J, Krishnaswami A, Alexander KP, Gerstenblith G, Cawthon P, deFilippi CR, Goyal P (2023) Sarcopenia and cardiovascular diseases. Circulation 147(20):1534–1553
Article PubMed PubMed Central Google Scholar
Kamiya K, Hamazaki N, Matsue Y, Mezzani A, Corrà U, Matsuzawa R, Nozaki K, Tanaka S, Maekawa E, Noda C, Yamaoka-Tojo M, Matsunaga A, Masuda T, Ako J (2018) Gait speed has comparable prognostic capability to six-minute walk distance in older patients with cardiovascular disease. Eur J Prev Cardiol 25(2):212–219
Kamiya K, Sato Y, Takahashi T, Tsuchihashi-Makaya M, Kotooka N, Ikegame T, Takura T, Yamamoto T, Nagayama M, Goto Y, Makita S, Isobe M (2020) Multidisciplinary cardiac rehabilitation and long-term prognosis in patients with heart failure. Circ Heart Fail 13(10):e006798
Matsue Y, Kamiya K, Saito H, Saito K, Ogasahara Y, Maekawa E, Konishi M, Kitai T, Iwata K, Jujo K, Wada H, Kasai T, Nagamatsu H, Ozawa T, Izawa K, Yamamoto S, Aizawa N, Yonezawa R, Oka K, Momomura SI, Kagiyama N (2020) Prevalence and prognostic impact of the coexistence of multiple frailty domains in elderly patients with heart failure: the FRAGILE-HF cohort study. Eur J Heart Fail 22(11):2112–2119
Article CAS PubMed Google Scholar
Ueno K, Kamiya K, Hamazaki N, Nozaki K, Ichikawa T, Yamashita M, Uchida S, Noda T, Maekawa E, Yamaoka-Tojo M, Matsunaga A, Ako J (2022) Usefulness of measuring maximal gait speed in conjunction with usual gait speed for risk stratification in patients with cardiovascular disease. Exp Gerontol 164:111810
Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S, Kojima T, Kuzuya M, Lee JSW, Lee SY, Lee WJ, Lee Y, Liang CK, Lim JY, Lim WS, Peng LN, Sugimoto K, Tanaka T, Won CW, Yamada M, Zhang T, Akishita M, Arai H (2020) Asian Working Group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 21(3):300-307.e302
Osman M, Benjamin MM, Balla S, Kheiri B, Bianco C, Sengupta PP, Daggubati R, Malla M, Liu SV, Mamas M, Patel B (2022) Index admission and thirty-day readmission outcomes of patients with cancer presenting with STEMI. Cardiovasc Revasc Med 35:121–128
Wang F, Gulati R, Lennon RJ, Lewis BR, Park J, Sandhu GS, Wright RS, Lerman A, Herrmann J (2016) Cancer history portends worse acute and long-term noncardiac (but not cardiac) mortality after primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Mayo Clin Proc 91(12):1680–1692
Comments (0)